The estimated Net Worth of Paula A Price is at least $4.32 Миллион dollars as of 21 December 2023. Ms. Price owns over 551 units of Accenture plc stock worth over $2,306,091 and over the last 18 years she sold ACN stock worth over $1,673,339. In addition, she makes $344,884 as Independent Director at Accenture plc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Price ACN stock SEC Form 4 insiders trading
Paula has made over 12 trades of the Accenture plc stock since 2014, according to the Form 4 filled with the SEC. Most recently she sold 551 units of ACN stock worth $190,293 on 21 December 2023.
The largest trade she's ever made was selling 4,150 units of Accenture plc stock on 31 January 2022 worth over $215,053. On average, Paula trades about 98 units every 26 days since 2007. As of 21 December 2023 she still owns at least 6,583 units of Accenture plc stock.
You can see the complete history of Ms. Price stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paula Price biography
Paula A. Price is Independent Director of the Company. She has been the chief financial officer of Macy’s, Inc., an omni-channel retailer of apparel, accessories and other goods, since July 2018. From 2014 to 2018, she was a full-time senior lecturer at Harvard Business School. Prior to joining the faculty of Harvard Business School, she was executive vice president and chief financial officer of Ahold USA, a U.S. grocery retailer, which she joined in 2009. Prior to joining Ahold USA, Ms. Price was senior vice president, controller and chief accounting officer at CVS Caremark. Earlier in her career, Ms. Price was the chief financial officer of the Institutional Trust Services division of JPMorgan Chase & Co. and also held senior management positions at Prudential Insurance Co. of America, Diageo and Kraft Foods. A certified public accountant, she began her career at Arthur Andersen & Co. Ms. Price previously served as a director of Dollar General Corporation from 2014 to 2018 and Western Digital Corporation from 2014 to 2019.
What is the salary of Paula Price?
As the Independent Director of Accenture plc, the total compensation of Paula Price at Accenture plc is $344,884. There are 9 executives at Accenture plc getting paid more, with David Rowland having the highest compensation of $15,031,900.
How old is Paula Price?
Paula Price is 58, she's been the Independent Director of Accenture plc since 2014. There are 12 older and 17 younger executives at Accenture plc. The oldest executive at Accenture plc is Herbert Hainer, 65, who is the Independent Director.
What's Paula Price's mailing address?
Paula's mailing address filed with the SEC is C/O ACCENTURE, 500 W. MADISON STREET, CHICAGO, IL, 60661.
Insiders trading at Accenture plc
Over the last 14 years, insiders at Accenture plc have traded over $571,571,901 worth of Accenture plc stock and bought 20,000 units worth $1,439,800 . The most active insiders traders include Beth E Mooney, Venkata S M Renduchintala и Pierre Nanterme. On average, Accenture plc executives and independent directors trade stock every 8 days with the average trade being worth of $2,487,902. The most recent stock trade was executed by Ellyn Shook on 23 July 2024, trading 5,000 units of ACN stock currently worth $1,649,100.
What does Accenture plc do?
Accenture plc is an Irish-American professional services company based in Dublin, specializing in information technology services and consulting. A Fortune Global 500 company, it reported revenues of $61.6 billion in 2022.
What does Accenture plc's logo look like?
Complete history of Ms. Price stock trades at Mondelez International, Western Digital, Accenture plc, Bristol-Myers Squibb Co, CVS Health Corp, DaVita Inc, Dollar General и Macy`s Inc
Accenture plc executives and stock owners
Accenture plc executives and other stock owners filed with the SEC include:
-
David Rowland,
Executive Chairman of the Board -
Julie T. Spellman Sweet,
CEO & Chairman -
Julie Sweet,
Chief Executive Officer, Director -
Gianfranco Casati,
Group Chief Executive - Growth Markets -
Gianfranco Casati,
Chief Exec. Officer of Growth Markets -
KC McClure,
Chief Financial Officer -
Jean-Marc Ollagnier,
Chief Exec. Officer of Europe -
Kathleen R. McClure,
Chief Financial Officer -
David P. Rowland,
Exec. Chairman & Advisor to CEO -
Paula Price,
Independent Director -
Jaime Ardila,
Independent Director -
Nancy McKinstry,
Independent Director -
Tracey Travis,
Independent Director -
Gilles Christian Pelisson,
Lead Independent Director -
Arun Sarin,
Independent Director -
Herbert Hainer,
Independent Director -
Venkata Renduchintala,
Independent Director -
Frank Tang,
Independent Director -
Joel Unruch,
Chief Compliance Officer, General Counsel, Secretary -
James Etheredge,
Chief Executive, North America -
Domingo Miron,
Group Chief Executive - Financial Services -
Simon Eaves,
Group Chief Executive - Products Operating Group -
John Walsh,
Group Chief Executive Officer - Communications, Media and Technology -
Richard Clark,
Chief Accounting Officer, Corporate Controller -
Ellyn Shook,
Chief Human Resource Officer, Chief Leadership Officer -
Johan Deblaere,
Chief Operating Officer, Chief Executive - Europe -
Jean-Marc Ollagnier,
Group Chief Executive - Resources Operating Group -
Daniel London,
Group Chief Executive - Health & Public Service Operating Group -
Jill Kramer,
Chief Marketing & Communications Officer -
Joel Unruch,
Gen. Counsel & Corp. Sec. -
Joel F. Unruch,
Gen. Counsel & Corp. Sec. -
Angie Park,
Managing Director & Head of Investor Relations -
Paul R. Daugherty,
Group Chief Exec. of Technology & CTO -
Richard P. Clark,
Chief Accounting Officer & Chief Transformation Officer  Bus. Enablement -
Johan G. Deblaere,
Chief Operating Officer -
Omar Abbosh,
Grp Chief Exec-Com, Med & Tech -
Charles H Giancarlo,
Director -
Dina Dublon,
Director -
William L Kimsey,
Director -
Robert E Sell,
Grp Chief Exec-Com, Med & Tech -
Marjorie Magner,
Director -
Chad T Jerdee,
General Counsel and CCO -
Wulf Von Schimmelmann,
Director -
Blythe J Mcgarvie,
Director -
Beth E Mooney,
Director -
Leonardo Framil,
CEO-Growth Markets -
Melissa A Burgum,
Chief Accounting Officer -
Kathleen R Mc Clure,
Chief Financial Officer -
Stephen J Rohleder,
Group Chief Exec-Health & PS -
Mark Moodystuart,
Director -
Nobuyuki Idei,
Director -
Michael J Salvino,
Group Chief Exec-Bus Proc Out -
Shawn Collinson,
Sr Managing Dir-Growth & Strat -
Martin I Cole,
Grp Chief Exec-Comm & HighTech -
'T Noordende Alexander M Van,
Group Chief Exec-Products -
Pierre Nanterme,
Chief Executive Officer -
Jill Smart,
Chief Human Resources Officer -
Richard Lumb,
Group Chief Executive-Fin Serv -
Robert I Lipp,
Director -
William D Green,
Chairman -
Anthony G Coughlan,
Principal Accounting Officer -
Pamela J. Craig,
Chief Financial Officer -
Dennis F Hightower,
Director -
Jeffrey D Osborne,
Chief Performance Officer -
Kevin M Campbell,
Group Chief Exec-Technology -
Robert N Frerichs,
Group Chief Exec-North America -
Martin Brudermueller,
Director -
Alan C. Jope,
Director -
Angela Beatty,
Chief Leadership & HR Officer -
Manish Sharma,
CEO-Americas